Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III PREOB in early non-traumatic osteonecrosis of the femoral head
NL-OMON45063Phase 3Active, not recruiting
- Sponsor
- BioSenic
- Start
- Oct 2014
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteonecrosis of the hip comparing PREOB + core decompression with Placebo + core decompression (2 arms). Primary endpoints: Primary efficacy endpoint, Clinical response component and 1 more. Started Oct 2014; status: active, not recruiting.
02
Drugs
PREOB
03
Conditions
osteonecrosis of the hip
Beyond the preview
Go deeper on NL-OMON45063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45063.